about
Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines.CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo.Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype.The functional interaction between Acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target.Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cellsGanglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer.The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models.Cancer antigen prioritization: a road map to work in defining vaccines against specific targets. A point of view.RAC3 more than a nuclear receptor coactivator: a key inhibitor of senescence that is downregulated in aging.Telomere structure and telomerase in health and disease (review).Reduction of tumor angiogenesis induced by desmopressin in a breast cancer modelExogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines.Protein universe containing a PUA RNA-binding domain.Mechanisms of cellular uptake, intracellular transportation, and degradation of CIGB-300, a Tat-conjugated peptide, in tumor cell lines.Structure-activity relationship of 1-desamino-8-D-arginine vasopressin as an antiproliferative agent on human vasopressin V2 receptor-expressing cancer cells.The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells.A purified GM3 ganglioside conjugated vaccine induces specific, adjuvant-dependent and non-transient antitumour activity against B16 mouse melanoma in vitro and in vivo.Desmopressin inhibits lung and lymph node metastasis in a mouse mammary carcinoma model of surgical manipulation.Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cells.Role of cell surface GM3 ganglioside and sialic acid in the antitumor activity of a GM3-based vaccine in the murine B16 melanoma model.Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.Novel insights into the evolution and structural characterization of dyskerin using comprehensive bioinformatics analysis.Differential expression of Shh and BMP signaling in the potential conversion of human adipose tissue stem cells into neuron-like cells in vitro.Addition of vasopressin synthetic analogue [V(4)Q(5)]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models.Homology Model and Docking-Based Virtual Screening for Ligands of Human Dyskerin as New Inhibitors of Telomerase for Cancer TreatmentTelomeropathies: Etiology, diagnosis, treatment and follow-up. Ethical and legal considerationsPartial characterization of novel serine proteinase inhibitors from human umbilical vein endothelial cells.Expression of gelatinase/type IV collagenase in tumor necrosis correlates with cell detachment and tumor invasionIn vivo selection and characterization of a murine mammary tumor subline with high potential for spontaneous lymph node metastasisImmunomagnetic separation as a final purification step of liver endothelial cellsUlex europaeus I lectin induces activation of matrix-metalloproteinase-2 in endothelial cellsEffect of host-organ environment on the in vivo and in vitro behavior of a murine mammary adenocarcinomaAntimetastatic effect of desmopressin in a mouse mammary tumor modelIn vitro activity of a Solanum tuberosum extract against mammary carcinoma cellsIrreversible telomere shortening by 3'-azido-2',3'-dideoxythymidine (AZT) treatmentReduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesisComplete antitumor protection by perioperative immunization with GM3/VSSP vaccine in a preclinical mouse melanoma modelPerioperative desmopressin prolongs survival in surgically treated bitches with mammary gland tumours: a pilot studyEffect of atorvastatin in a case of feline multicentric lymphoma - Case reportTranscriptional characterization of Wnt and Notch signaling pathways in neuronal differentiation of human adipose tissue-derived stem cells
P50
Q31140123-C4AAF5E3-7F1B-456C-B665-24F22573683EQ33346339-EC2621FA-94DD-4A0B-8C1B-74BCC9CED5B9Q33687878-207C7C8D-F17E-4AFF-B438-743BC8FE947FQ34342416-19AD2989-4CEF-4BDC-8127-A5E36290625DQ34446327-FD8A73BA-661F-45A7-B026-7BFA0E45299DQ35623390-47DA2A6E-9391-4F6A-9DF7-FABC30C86B35Q35636438-2ACCA445-42AA-4349-A9EE-16CA639B8702Q36063243-B80820B0-8FF2-4F35-8F4D-F358CBA2CF8AQ36246392-245B4738-AD72-45B1-9658-BD5CBDD4EBE4Q36643073-B2E32DBE-4837-40D3-B507-C0D2A5AD5F15Q37302108-26E46051-85ED-4BA0-8844-198FA8B77895Q37483080-BD80B4C2-9120-484E-A434-CD36F83CDD63Q38176105-1AE2FDFF-F453-404C-81B5-7B415D25D99DQ39000756-DF714152-1247-4DFC-A30E-A396AF8E3546Q39003702-FCAE0F17-4E9C-4C1E-B79C-F086C0F8BA2DQ40672172-8E5670C1-AB14-4F8D-BA7F-662446EA9DFFQ43684989-F455724C-297B-45E4-8E1E-D138937F9E9EQ44124448-AEAAFC04-A9D1-4961-BA6B-A58BBEA92C8AQ44197472-A55BC376-D259-4DEC-A233-0D7EBDCF180CQ44243565-1E406256-44B3-4046-93D4-9335222F8D5BQ44912803-D63577AF-13DF-482D-9433-2F530A706932Q46794554-1EAE6DDD-8868-4BF4-83FE-70062CA4C407Q48124954-84106011-F0FA-4217-96C5-FB9ECFF8CD9AQ53788180-03744A8B-065A-4D92-A8F5-A7C627AFAC40Q57812384-209CD5D5-EA31-4A7A-A907-DD401F2D49CDQ64040181-A01CDF08-2D79-4F70-B762-FE9EADD7798BQ64890653-A45E6DC7-D3B2-4367-A50A-D33ED337EBC9Q67488269-AE462605-CF2D-41A4-837E-F1DE57342A3BQ68591593-E0667B8E-80EE-4029-88D6-8795B5ABCDC7Q70465307-E715AADD-B48E-4E32-A622-2881F5BBAEB6Q71560800-97FC3454-9561-464D-82E1-0C43F28BE9C7Q72886511-37EB8B10-D3B8-4BF2-AED2-E46F08565454Q73316234-85490F15-C847-42B5-8D10-51590B87F6C6Q73748098-D683CE7D-291D-40ED-8ABB-0C863C6C38FAQ74585988-6D6A3A7B-C6AF-419F-A648-E32DA56D3EF0Q77513498-62671E70-DAAB-46AC-8531-176B784C697BQ79405036-0CB74918-926C-40C5-B32F-EE0E6EDFAF9BQ80844510-844E0990-8ADE-4EA8-B7D2-CBC4827DCC46Q83483763-F11F3D4B-FABB-4095-B25F-4ED570CDB87EQ83498615-CA91DC5D-E070-40A7-B2F3-0F489E2AE37D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daniel Eduardo Gómez
@ast
Daniel Eduardo Gómez
@en
Daniel Eduardo Gómez
@es
Daniel Eduardo Gómez
@fr
Daniel Eduardo Gómez
@nl
Daniel Eduardo Gómez
@sl
type
label
Daniel Eduardo Gómez
@ast
Daniel Eduardo Gómez
@en
Daniel Eduardo Gómez
@es
Daniel Eduardo Gómez
@fr
Daniel Eduardo Gómez
@nl
Daniel Eduardo Gómez
@sl
prefLabel
Daniel Eduardo Gómez
@ast
Daniel Eduardo Gómez
@en
Daniel Eduardo Gómez
@es
Daniel Eduardo Gómez
@fr
Daniel Eduardo Gómez
@nl
Daniel Eduardo Gómez
@sl
P106
P1153
7102289869
P21
P31
P496
0000-0002-8629-0787